Kim Andrews

1.2k total citations
44 papers, 900 citations indexed

About

Kim Andrews is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Kim Andrews has authored 44 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Oncology. Recurrent topics in Kim Andrews's work include Diabetes Treatment and Management (10 papers), Neuropeptides and Animal Physiology (6 papers) and Peptidase Inhibition and Analysis (5 papers). Kim Andrews is often cited by papers focused on Diabetes Treatment and Management (10 papers), Neuropeptides and Animal Physiology (6 papers) and Peptidase Inhibition and Analysis (5 papers). Kim Andrews collaborates with scholars based in United States, Saudi Arabia and India. Kim Andrews's co-authors include Janice C. Parker, Adam A. Pack, Melanie Allen, Whitlow W. L. Au, Mark H. Deakos, John D. McNeish, Jeffrey L. Stock, Louis M. Herman, Marc O. Lammers and Malcolm K. McGowan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and Diabetes.

In The Last Decade

Kim Andrews

42 papers receiving 867 citations

Peers

Kim Andrews
Michael J. Watson United States
Richard E. Honkanen United States
Jaime E. Dickerson United States
Ramani A. Kandasamy United States
Michael J. Watson United States
Kim Andrews
Citations per year, relative to Kim Andrews Kim Andrews (= 1×) peers Michael J. Watson

Countries citing papers authored by Kim Andrews

Since Specialization
Citations

This map shows the geographic impact of Kim Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Andrews more than expected).

Fields of papers citing papers by Kim Andrews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Andrews. The network helps show where Kim Andrews may publish in the future.

Co-authorship network of co-authors of Kim Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Andrews. A scholar is included among the top collaborators of Kim Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Andrews. Kim Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mir, M. Amin, Md. Mostaured Ali Khan, Bimal Krishna Banik, et al.. (2025). Microplastics in food products: Prevalence, artificial intelligence based detection, and potential health impacts on humans. Emerging contaminants. 11(2). 100477–100477. 6 indexed citations
2.
Abdelli, Nouara, et al.. (2025). Artificial intelligence applications in food science: a review of cutting-edge technologies. Cogent Food & Agriculture. 12(1).
3.
Mir, M. Amin, et al.. (2025). Pharmaceuticals and personal care products as emerging contaminants: environmental fate, detection, and mitigation strategies. International Journal of Environmental & Analytical Chemistry. 105(20). 8837–8865. 13 indexed citations
4.
Mir, M. Amin, et al.. (2024). Heavy metal and mycotoxin-producing fungi contamination of coffee consumed in Saudi Arabia. SHILAP Revista de lepidopterología. 5. 100798–100798. 2 indexed citations
5.
Mir, M. Amin, et al.. (2024). Colour pigment from plants - Anthocyanin as an acid base indicator. AIP conference proceedings. 3122. 20005–20005. 1 indexed citations
6.
Mir, M. Amin, M. Waqar Ashraf, Kim Andrews, Syed M. Hasnain, & Ajay Singh. (2024). Transition metal complexes of (Ti, V, Cr and Mn,) and Pyrolidine-2-carboxylic acid synthesis, characterization and antimicrobial activity. AIP conference proceedings. 3122. 20004–20004.
7.
Mir, M. Amin, et al.. (2023). Determination of Metals, Fungi and Mycotoxins in Cat Meal Samples used in Saudi Arabia. Biomedical & Pharmacology Journal. 16(3). 1761–1768. 1 indexed citations
8.
Mir, M. Amin, et al.. (2023). Molecular Dynamic, Hirshfeld Surface, Computational Quantum andSpectroscopic analysis of 4-Hydroxy-1-Naphthaldehyde. Current Organocatalysis. 11(1). 60–70. 2 indexed citations
9.
DeNinno, Michael P., Stephen W. Wright, John B. Etienne, et al.. (2012). Discovery of triazolopyrimidine-based PDE8B inhibitors: Exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes. Bioorganic & Medicinal Chemistry Letters. 22(17). 5721–5726. 22 indexed citations
10.
Andrews, Kim, David A. Beebe, John W. Benbow, et al.. (2011). 1-((3S,4S)-4-Amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 21(6). 1810–1814. 16 indexed citations
11.
Ammirati, Mark, Kim Andrews, Dennis E. Danley, et al.. (2009). (3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: A potent, selective, orally active dipeptidyl peptidase IV inhibitor. Bioorganic & Medicinal Chemistry Letters. 19(7). 1991–1995. 33 indexed citations
12.
Wright, Stephen W., Mark Ammirati, Kim Andrews, et al.. (2007). (3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: Synthesis, in vitro, in vivo, and X-ray crystallographic characterization. Bioorganic & Medicinal Chemistry Letters. 17(20). 5638–5642. 13 indexed citations
13.
Hulin, Bernard, et al.. (2005). New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(21). 4770–4773. 26 indexed citations
14.
Parker, Janice C., Kim Andrews, Melanie Allen, Jeffrey L. Stock, & John D. McNeish. (2002). Glycemic Control in Mice with Targeted Disruption of the Glucagon Receptor Gene. Biochemical and Biophysical Research Communications. 290(2). 839–843. 124 indexed citations
16.
Parker, Jeremy C., Kim Andrews, Walter Massefski, et al.. (1998). Structure‐function analysis of a series of glucagon‐like peptide‐1 analogs. Journal of Peptide Research. 52(5). 398–409. 31 indexed citations
17.
Parker, Janice C., Maria A. VanVolkenburg, Nancy A. Nardone, Diane M. Hargrove, & Kim Andrews. (1997). Modulation of Insulin Secretion and Glycemia by Selective Inhibition of Cyclic AMP Phosphodiesterase III. Biochemical and Biophysical Research Communications. 236(3). 665–669. 25 indexed citations
18.
Hargrove, Diane M., et al.. (1996). Comparison of the glucose dependency of glucagon-like peptide-1(7–37) and glyburide in vitro and in vivo. Metabolism. 45(3). 404–409. 14 indexed citations
19.
Kreutter, David K., Stephen Orena, & Kim Andrews. (1989). Suppression of insulin-Stimulated glucose transport in L6 myocytes by calcitonin gene-related peptide. Biochemical and Biophysical Research Communications. 164(1). 461–467. 19 indexed citations
20.
Andrews, Kim, et al.. (1988). Determination of Parameters for Enzyme Therapy Using L‐Asparaginase Entrapped in Canine Erythrocytes. Biotechnology and Applied Biochemistry. 10(4). 365–372. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026